Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors

Written By Lara Wilson
Lara Wilson
Previous

Windfall Announces New Hires to Executive Leadership Team to Accelerate Next Phase of Growth
Next

Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes